Washburn Capital Management’s AbbVie ABBV Stock Holding History

Washburn Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.22M	Sell	4,839 -103	-2%	-$22.2K	0.6%	29
2026 Q1	$1.07M	Sell	4,942 -227	-4%	-$50.4K	0.62%	28
2025 Q4	$1.18M	Sell	5,169 -54	-1%	-$12.3K	0.65%	27
2025 Q3	$1.21M	Sell	5,223 -212	-4%	-$43.2K	0.68%	23
2025 Q2	$1.01M	Sell	5,435 -43	-0.8%	-$7.99K	0.59%	26
2025 Q1	$1.15M	Buy	5,478 +521	+11%	+$101K	0.75%	20
2024 Q4	$881K	Sell	4,957 -222	-4%	-$40.8K	0.55%	23
2024 Q3	$1.02M	Sell	5,179 -53	-1%	-$9.89K	0.73%	21
2024 Q2	$897K	Sell	5,232 -148	-3%	-$24.5K	0.64%	22
2024 Q1	$980K	Buy	5,380 +58	+1%	+$10K	0.72%	21
2023 Q4	$825K	Sell	5,322 -217	-4%	-$31.6K	0.62%	21
2023 Q3	$826K	Sell	5,539 -362	-6%	-$53.1K	0.7%	24
2023 Q2	$795K	Sell	5,901 -4,852	-45%	-$712K	0.66%	24
2023 Q1	$1.71M	Sell	10,753 -2,617	-20%	-$400K	1.48%	13
2022 Q4	$2.16M	Buy	13,370 +508	+4%	+$77.9K	1.97%	11
2022 Q3	$1.73M	Sell	12,862 -72	-0.6%	-$10.3K	1.65%	13
2022 Q2	$1.98M	Sell	12,934 -512	-4%	-$78.2K	1.71%	13
2022 Q1	$2.18M	Sell	13,446 -827	-6%	-$120K	1.43%	13
2021 Q4	$1.93M	Sell	14,273 -1,995	-12%	-$236K	1.15%	20
2021 Q3	$1.75M	Sell	16,268 -850	-5%	-$97.1K	1.15%	19
2021 Q2	$1.93M	Sell	17,118 -926	-5%	-$104K	1.29%	17
2021 Q1	$1.95M	Buy	18,044 +632	+4%	+$67.6K	1.33%	19
2020 Q4	$1.87M	Sell	17,412 -890	-5%	-$85.5K	1.3%	18
2020 Q3	$1.6M	Buy	18,302 +4,116	+29%	+$388K	1.27%	20
2020 Q2	$1.39M	Buy	14,186 +4,801	+51%	+$423K	1.28%	20
2020 Q1	$715K	Buy	9,385 +2,325	+33%	+$198K	0.98%	21
2019 Q4	$625K	Buy	+7,060	New	+$586K	0.57%	22

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Washburn Capital Management's ABBV Position: Q2 2026 in Review

Washburn Capital Management reduced its AbbVie (ABBV) stake by 2.1% in Q2 2026, selling an estimated $22.2K and leaving 4,839 shares worth $1.22M. The position accounts for 0.6% of the portfolio, ranked #29.

Washburn Capital Management first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.18M in Q1 2022. 1,631 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Washburn Capital Management held 4,839 shares of AbbVie worth $1.22M as of Q2 2026.
Washburn Capital Management sold 103 AbbVie shares in Q2 2026, an estimated $22.2K.
AbbVie made up 0.6% of Washburn Capital Management's portfolio in Q2 2026, its #29 holding.
Washburn Capital Management first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
Washburn Capital Management's AbbVie position peaked at $2.18M in Q1 2022.
1,631 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Washburn Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.